Vertos reports long-term safety and efficacy of mild in patients with LSS

Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.

Read more...

Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … – Earthtimes

Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … Earthtimes Vertos Medical was founded to advance the treatment of patients suffering with lumbar spinal stenosis (LSS), a degenerative, age-related narrowing of the …

Read more...

Vertos Medical announces positive results from IRB I Patient Outcomes Trial of ‘mild’ for LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS)

Read more...

Vertos Medical’s Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild® (Business Wire via Yahoo! Finance)

ALISO VIEJO, Calif.—-Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild* for the treatment of lumbar spinal stenosis .

Read more...

Observational study on mild demonstrates acute safety of procedure in treatment of LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Read more...

Observational study on mild demonstrates acute safety of procedure in treatment of LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Read more...

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Read more...

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Read more...

Acute Study Demonstrates Safety of Vertos Medical’s mild® Procedure; Findings Appear in Pain Physician Journal (Business Wire via Yahoo! Finance)

ALISO VIEJO, Calif.—-Medical device company Vertos Medical Inc.

Read more...

Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology

Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing.

Read more...